Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. WuXi Biologics (Cayman) Inc.
  6. News
  7. Summary
    2269   KYG970081173

WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shanghai stocks fall as coal shares drag; Hong Kong rebounds

09/17/2021 | 12:53am EDT

SHANGHAI, Sept 17 (Reuters) - Shanghai stocks fell on Friday, with coal companies leading the declines, while China's blue-chips edged higher. The Hong Kong market rebounded, led by tech and healthcare shares.

The CSI300 index rose 0.3% to 4,820.76 at the end of the morning session, while the Shanghai Composite Index lost 0.6% to 3,585.71.

The Hang Seng index added 0.4% to 24,765.45. The Hong Kong China Enterprises Index gained 0.9% to 8,885.08.

** A sub-index tracking coal stocks plunged 7%, their biggest daily decline since February 2020.

** China's leading coal industry associations called on top miners on Thursday to ensure thermal coal supplies to help stabilise surging prices, at a time when the country's environment ministry said China plans to include more cities in its 2021 winter air pollution campaign.

** Investors bought the dips in the battered real estate sector, which rebounded 2% after falling for three straight sessions on China Evergrande Group's debt crisis.

** Goldman Sachs, JPMorgan warned Evergrande's crisis could pose spillover risks to the broader Chinese property sector.

** The healthcare sub-index and the consumer staples gained 3.4% and 1.6%, respectively.

** In Hong Kong, the benchmark rebounded after posting its lowest close in 10 months the day before, as the saga around China Evergrande Group lurched towards a conclusion, unsettling investors.

** Shares of Evergrande extended falls for the fifth consecutive session, slumping 11.8% to HK$2.32, their lowest in nearly ten years.

** The Hang Seng Property Index and the Hang Seng Finance Index went down 0.9% and 1.5%, respectively.

** The Hang Seng Tech Index jumped 2.9% after losing 1% in previous session. Internet giants Tencent Holdings , Alibaba Group, and Meituan gained 2.2%, 1.7%, and 3.7%, respectively.

** The healthcare sub-index surged 4.2%, and Alibaba Health Information Technology and Wuxi Biologics are the top two daily gainers on the Hang Seng Index. (Reporting by Shanghai Newsroom)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ALIBABA GROUP HOLDING LIMITED 0.10% 177.18 Delayed Quote.-23.87%
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED 13.49% 12.62 End-of-day quote.-44.89%
CHINA EVERGRANDE GROUP -3.91% 2.95 End-of-day quote.-80.20%
MEITUAN 2.87% 293.8 End-of-day quote.-0.27%
S&P/CITIC 300 INDEX 0.38% 4470.37 Delayed Quote.-2.85%
TENCENT HOLDINGS LIMITED 2.10% 509.5 End-of-day quote.-9.66%
WUXI BIOLOGICS (CAYMAN) INC. -1.02% 116.7 End-of-day quote.13.52%
All news about WUXI BIOLOGICS (CAYMAN) INC.
10/18CHINA EVERGRANDE : Hong Kong shares close higher despite China's weak growth data
RE
10/08Hong Kong shares close 0.6% higher as tech and financial stocks gain
RE
10/08LI NING : China stocks rise on strong services data, easing Sino-U.S. tensions
RE
09/30SIHUAN PHARMACEUTICAL : Pharma, WuXi Bio Units to Collaborate on Breast Cancer Drug Candid..
MT
09/17Hong Kong shares rebound, led by tech, healthcare
RE
09/17Shanghai stocks fall as coal shares drag; Hong Kong rebounds
RE
09/14Hong Kong shares end lower, dragged by property, financials and tech
RE
09/06Hong Kong shares rise, led by tech and financials
RE
09/01Hong Kong shares rise as tech, financial sectors gain
RE
09/01WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global ..
CI
More news
Analyst Recommendations on WUXI BIOLOGICS (CAYMAN) INC.
More recommendations
Financials
Sales 2021 9 538 M 1 492 M 1 492 M
Net income 2021 2 971 M 465 M 465 M
Net cash 2021 5 831 M 912 M 912 M
P/E ratio 2021 135x
Yield 2021 -
Capitalization 407 B 63 685 M 63 695 M
EV / Sales 2021 42,1x
EV / Sales 2022 28,5x
Nbr of Employees 7 686
Free-Float 84,4%
Chart WUXI BIOLOGICS (CAYMAN) INC.
Duration : Period :
WuXi Biologics (Cayman) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI BIOLOGICS (CAYMAN) INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 95,98 CNY
Average target price 129,59 CNY
Spread / Average Target 35,0%
EPS Revisions
Managers and Directors
Zhi Sheng Chen Chief Executive Officer & Executive Director
Shao Hua Lu-Wong Co-Chief Financial Officer
Ming Tu Co-Chief Financial Officer & Executive VP
Ge Li Non-Executive Chairman
Weichang Zhou Executive Director, Chief Technology Officer & EVP
Sector and Competitors